Pyridoxal

From NuGOwiki

(Redirected from HMDB01545)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Pyridoxal
2D structure for Pyridoxal
Chemical Name 3-hydroxy-5-(hydroxymethyl)-2-methyl-pyridine-4-carbaldehyde
Chemical Formula C8H9NO3
CAS Number 66-72-8
Chemical Information HMDB01545
Biochemical Taxonomy

  • Pyridoxals and Derivatives

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Nicotinate and Nicotinamide Metabolism
  • Valine, Leucine and Isoleucine Degradation
  • Vitamin B6 Metabolism

Biofluid Location

  • Blood

Tissue Location

  • Fibroblasts
  • Kidney
  • Placenta
  • Erythrocyte

Normal Biofluid Concentrations

  • Blood: 0.251 +/- 0.051 uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Sickle cell disease-SS (SCD-SS)

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Sickle cell disease-SS (SCD-SS)): 0.036 +/- 0.031 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
The 4-carboxyaldehyde form of vitamin B6 which is converted to pyridoxal phosphate which is a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid.

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Sickle cell disease-SS (SCD-SS)

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines